The United States is experiencing a rapid surge in flu cases, driven by a new variant of the virus known as “subclade K.” This variant has already led to early outbreaks in countries such as the United Kingdom, Japan, and Canada. According to the Centers for Disease Control and Prevention (CDC), more than half of the states in the US are currently reporting high or very high levels of illness.
Understanding the Subclade K Variant
The flu virus is known for its ability to mutate, resulting in multiple forms and subtypes. Subclade K is a mutated version of the H3N2 strain, which is particularly harsh, especially for older adults. While the mutations in subclade K are not significant enough to be considered a new kind of flu, they are sufficient to evade some of the protection offered by this year’s vaccine, according to Andrew Pekosz, a virus expert at Johns Hopkins Bloomberg School of Public Health.
Impact of Subclade K on Public Health
The CDC has reported at least 7.5 million illnesses, 81,000 hospitalizations, and 3,100 deaths from flu so far this season, including at least eight child deaths. Some states, such as New York, are particularly hard-hit, with the week ending December 20 marking the most flu cases recorded in a single week since 2004. Despite the concerning numbers, it’s too early to determine if this flu season will be as severe as the previous one.
Vaccination and Prevention
Health experts emphasize that it’s not too late to get a flu shot, which can still prevent severe illness even if someone gets infected. Although this year’s vaccine isn’t a perfect match for the subclade K strain, preliminary analysis from the UK found it offers at least partial protection, lowering people’s risk of hospitalization. The CDC recommends a flu vaccine for everyone aged 6 months and older, with a particular emphasis on vulnerable groups such as people 65 and older, pregnant women, young children, and those with chronic health problems.
Who Should Get Vaccinated?
The CDC and major medical societies recommend a flu vaccine for almost everyone, with few exceptions. The vaccines are designed to protect against three influenza strains and appear to be a good match against H1N1 and Type B flu that may also circulate this year. There are shots available for all ages, as well as the nasal spray FluMist for ages 2 to 49, and some people may be eligible to vaccinate themselves with FluMist at home.
For more information on the rising flu cases and the subclade K variant, visit Here
Image Source: www.latimes.com
